Related Experiment Video
Updated: Jun 26, 2025

09:41
A Pipeline for 3D Multimodality Image Integration and Computer-assisted Planning in Epilepsy Surgery
Published on: May 20, 2016
12.3K
Deep Learning Reconstruction for DWIs by EPI and FASE Sequences for Head and Neck Tumors
Hirotaka Ikeda1, Yoshiharu Ohno2,3, Kaori Yamamoto4
1Department of Radiology, Fujita Health University School of Medicine, Toyoake 470-1192, Aichi, Japan.
Cancers
|May 11, 2024
Summary
Fast advanced spin-echo (FASE) and deep learning reconstruction (DLR) improve diffusion-weighted imaging (DWI) quality for head and neck tumors. These techniques enhance signal-to-noise ratio without altering apparent diffusion coefficient measurements or tumor differentiation.
Area of Science:
- Radiology
- Medical Imaging
- Oncology
Background:
- Diffusion-weighted imaging (DWI) using echo-planar imaging (EPI) often suffers from susceptibility artifacts.
- Fast advanced spin-echo (FASE) and deep learning reconstruction (DLR) show promise for enhancing DWI quality.
Purpose of the Study:
- To evaluate the impact of FASE and DLR on DWI quality, apparent diffusion coefficient (ADC) accuracy, and the differentiation of malignant from benign head and neck tumors.
- To compare FASE and EPI sequences with and without DLR in both phantom and patient studies.
Main Methods:
- In vitro phantom studies assessed ADC correlation with standard values using Spearman's analysis.
- In vivo studies on head and neck tumor patients compared signal-to-noise ratio (SNR) and ADC between EPI and FASE sequences, with and without DLR, using Tukey's test.
Main Results:
- In vitro: Excellent correlation (ρ ≥ 0.92) between measured and standard ADC values.
- In vivo: FASE with DLR showed significantly higher SNR than FASE without DLR (p=0.02).
- ADC values differed significantly between sequences with and without DLR for both benign and malignant tumors (p<0.05).
Conclusions:
- FASE sequence and DLR significantly improve DWI image quality and reduce distortions compared to EPI.
- These advancements do not substantially affect ADC measurements or the ability to distinguish malignant from benign head and neck tumors.

